Low
₹499.85
High
₹506.90
| Previous Close | ₹503.65 |
|---|---|
| Day's Range | ₹499.85 - ₹506.90 |
| Open | ₹500.80 |
| 52 Week Range | ₹356.10 - ₹557.65 |
| Volume | 27,36,779 |
| Market Cap | ₹0.09 |
| Trade Value ( ₹ in Lacs) | 13,774.48 |
|---|---|
| Market Cap (₹ in Mn) | 0.09 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 177.50 |
| TTM EPS (₹) | 2.84 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 10.03 |
| PAT Margin (%) | 4.47 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 8.45 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 17275.69 | 66525.17 |
| Expenses | N/A | N/A |
| PBT | 2407.85 | 3853.56 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 2201.34 | 2973.4 |
| Founded | 2008 |
|---|---|
| Managing Director | Peyush Bansal |
| NSE Symbol | LENSKART |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,36,666.97 | 1,819.95 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,76,804.73 | 6,660.10 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,50,554.07 | 4,447.00 | 3,140.10 - 3,140.10 |
| Apollo Hospitals Enterprise Ltd. | 1,21,241.38 | 8,454.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,09,119.71 | 1,348.10 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,06,811.74 | 1,064.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,05,919.50 | 1,269.00 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,645.47 | 2,266.80 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 99,869.41 | 1,026.15 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 97,611.60 | 2,361.95 | 1,909.70 - 1,909.70 |
No Records Found
In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Lenskart Solutions has informed that it enclosed Shareholders’ Letter and Results dated May 20, 2026. The above information will also be hosted on the Company’s website at https://www.lenskart.com/corporate/investorrelations.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lenskart Solutions has informed that the Company will be hosting an Earnings Call with Analysts/Investors on Wednesday, May 20, 2026 at 05:00 PM (IST) to discuss the Financial Results for the quarter and year ended on March 31, 2026. The company has enclosed the mandatory pre-registration link for joining the Earnings Call. The above intimation will be made available on the website of the Company at https://www.lenskart.com/corporate/investorrelations.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Lenskart Solutions Ltd. is ₹503.65 as of 2026-06-17.
The market capitalisation of Lenskart Solutions Ltd. is ₹87,614.13 as of 2026-06-17.
The 1-year return of Lenskart Solutions Ltd. is 0.00% as of 2026-06-17.
The P/E ratio of Lenskart Solutions Ltd. is 0.00 as of 2026-06-18.
The 52-week high and low of Lenskart Solutions Ltd. are ₹557.65 and ₹356.10, respectively, as of 2026-06-17.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.